Global GLP-1 market hits US$62.81 billion in 2024, targeting US$299.08 billion by 2033 at 17.6% CAGR. Uncover trends in short-acting vs. long-acting types, Asia-Pacific's 19.8% growth, and major players like Novo Nordisk driving solutions for metabolic disorders. https://finance.yahoo.com/news/glucagon-peptide-1-analogues-market-140100995.html